company logo

Sr. Associate Scientist / Scientist I, Flow Cytometry in South San Francisco, CA

Save

compensation:

$100K - $150K*

specialty:

Life Sciences

experience:

5 - 7 years

Job Description

23andMe, the leading consumer genetics company, has accumulated a wealth of genotypic and phenotypic information from participants committed to improving human health through advances in genomics. Our Therapeutics team uses this data to discover and develop novel medicines to treat important diseases. The team currently has research programs across several therapeutic areas, including oncology, skin, respiratory and cardiovascular disease.

We are seeking a highly skilled and enthusiastic scientist to establish and manage a Flow Cytometry Core Facility at 23andMe Therapeutics in South San Francisco. You will be responsible for implementing best flow cytometry practices and working closely with our team on experiments contributing to therapeutic projects. The successful candidate will bring expertise in flow cytometry instrument set up and optimization, and a successful track record working cross-functionally. You will also be a strong team player with excellent organizational a

See More

Valid through: 2020-5-14

About 23andMe

23andMe is a privately held personal genomics and biotechnology company based in Mountain View, California. The company is named for the 23 pairs of chromosomes in a normal human cell. Its saliva-based direct-to-consumer personal genome test was named Invention of the Year by Time magazine in 2008. In 2013 the US Food and Drug Administration (FDA) ordered 23andMe to discontinue marketing its personal genome service (PGS), as the company had not obtained the legally required regulatory approval. That resulted in concerns about the potential consequences of customers receiving inaccurate health results. The company continued to sell a personal genome test without health-related results in the United States until October 21, 2015, when it announced that it would be including a revised health component with FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the United Kingdom since December 2014. The company was founded by Linda Avey, Paul Cusenza and Anne Wojcicki in 2006 to provide genetic testing and interpretation to individual consumers. In 2007, Google invested $3,900,000 in the company, along with Genentech, New Enterprise Associates, and Mohr Davidow Ventures.
Total Jobs:
10
Total Experts:
1
Average Pay:
$108,750
Total value of jobs:
$6,525,000
% Masters:
46%

23andMe Photos

company social media photocompany social media photocompany social media photocompany social media photo
Learn More About 23andMe
* Ladders Estimates